Silo Pharma, Inc. (SILO): Shareholders' Equity
$6.31M
As of 2025-12-31
$4.89M
As of 2026-06-30
-15.2%
3-year compound annual growth
+37.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.31M | +25.3% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $5.03M | -18.5% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $6.18M | -40.3% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $10.34M | +14.1% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $9.06M | +607.6% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $1.28M | n/m | 2022-03-28, Balance as of period end |
| 2019-12-31 | -$22.9K | n/m | 2021-05-17, Balance as of period end |
| 2018-12-31 | $407.4K | -66.1% | 2020-03-20, Balance as of period end |
| 2017-12-31 | $1.20M | n/a | 2019-04-04, Balance as of period end |
| No annual figure between 2013-12-31 and 2017-12-31. | |||
| 2013-12-31 | $1.79M | n/m | 2014-03-31, Balance as of period end |
| 2012-12-31 | -$41.2K | n/m | 2014-03-31, Balance as of period end |
| 2011-12-31 | -$1.7K | n/m | 2014-03-31, Balance as of period end |
| 2010-12-31 | $47.5K | n/a | 2013-03-05, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $41.98M | -54.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $2.76M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $224.89M | +82.1% |
Compare SILO, INO, CNTB, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗